Aldeyra Therapeutics Inc
ALDX
Get informed when a big investor buys or sells
+ FollowMarket Cap$82.04M
Close$
$0.91
32.8% downside
Current Fair Value
32.8% downsideOvervalued by 32.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $82.04 Million |
|---|---|
| Enterprise Value | $-38,946,256,963,348.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.56 |
| Beta | 1.19 |
| Outstanding Shares | 60,321,068 |
Return
| Return on Equity | -43.79% |
|---|---|
| Return on Assets | -34.90% |
| Return on Invested Capital | -45.92% |
Valuation & Multiples
| P/E Ratio | -3.51 |
|---|---|
| PEG | 7.95 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 2.24 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | -0.16 |
| Debt to Equity | 0.16 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
$31.33 M
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$2.50 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1302▼ 37.98% |
|---|---|
| Total Calls | 591,600▼ 7.58% |
| Total Puts | 77,000▼ 76.41% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 60.56%▼ 1.34% |
|---|---|
| Total Invested | $77.76M▲ 22.78% |
| Investors Holding | 114▼ 21.00% |
ESG Score
No data